TRNX Share Price

Open 20.45 Change Price %
High 20.86 1 Day 0.28 1.37
Low 20.32 1 Week 0.00 0.00
Close 20.67 1 Month 0.00 0.00
Volume 298097 1 Year 0.00 0.00
52 Week High 11.85
52 Week Low 0.00
TRNX Important Levels
Resistance 2 21.17
Resistance 1 20.96
Pivot 20.62
Support 1 20.38
Support 2 20.17
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
WRES 0.09 0.00%
SIRI 4.41 1.85%
QQQ 116.87 0.23%
More..
NASDAQ USA Top Gainers Stocks
LOCM 0.09 50.00%
ECTE 0.14 40.00%
BNSO 3.57 31.25%
FRAN 20.01 28.76%
FRAN 20.01 28.76%
FRAN 20.01 28.76%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
CRDS 5.45 25.87%
OTT 2.39 25.13%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
IMRS 0.02 -33.33%
More..

Tornier N.V. (NASDAQ: TRNX)

TRNX Technical Analysis 5
As on 1st Oct 2015 TRNX Share Price closed @ 20.67 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 25.34 & Strong Sell for SHORT-TERM with Stoploss of 23.80 we also expect STOCK to react on Following IMPORTANT LEVELS.
TRNX Target for December
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
TRNX Other Details
Segment EQ
Market Capital 716313472.00
Sector Healthcare
Industry Medical Instruments & Supplies
Offical website http://www.tornier.com
TRNX Address
TRNX
Prins Bernhardplein 200
Amsterdam, 1097 JB
Netherlands
Phone: 31 20 675 4002
Interactive Technical Analysis Chart Tornier N.V. ( TRNX NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Tornier N.V.
TRNX Business Profile
Tornier N.V. (Tornier) is a global medical device company focused on surgeons that treat musculoskeletal injuries and disorders of the shoulder, elbow, wrist, hand, ankle and foot. Tornier refers to these surgeons as extremity specialists. The Company sells to this extremity specialist customer base a broad line of joint replacement, trauma, sports medicine and biologic products to treat extremity joints. In certain international markets, it also offers joint replacement products for the hip and knee. The Company sells over approximately 100 product lines in approximately 40 countries. The Company�s principal products are organized in four categories: upper extremity joints and trauma, lower extremity joints and trauma, sports medicine and biologics, and large joints and other. The Company�s geographic regions consist of the United States, France and other areas. On October 4, 2012, the Company acquired OrthoHelix.